NEW YORK (TheStreet) -- With the Federal Reserve's decision to not taper, TheStreet's Jim Cramer told Mad Money research director Nicole Urken what sectors he thinks will finish strong this year.
Cramer suggested that investors stick with what's worked thus far in 2013, and likes high-growth biotech stocks in the low inflation environment. He likes Regeneron Pharmaceuticals (REGN), Celgene (CELG), Gilead Sciences (GILD), and Biogen Idec (BIIB).
Consumer-discretionary stocks, particularly GameStop (GME), should continue to do well, especially with the launch of Grand Theft Auto V.
Cramer said that financial stocks, despite a flat yield curve, should also do well.Stocks such as E-Trade Financial (ETFC), Charles Schwab Corp. (SCHW) and Lincoln National (LNC) should all be bought, although Lincoln National has been under pressure, he admitted. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV